DNA Replication

Replication is semi-conservative, meaning each new DNA molecule consists of one original strand and one newly synthesized strand. It begins at specific 'origins of replication' where DNA helicase unwinds the double helix, creating a replication fork. DNA polymerase III (in prokaryotes) or delta/epsilon (in eukaryotes) synthesizes the new strand by adding nucleotides in a 5' to 3' direction. Because DNA is antiparallel, one strand (the leading strand) is synthesized continuously toward the fork, while the other (the lagging strand) is synthesized discontinuously in short stretches called Okazaki fragments. RNA primase provides the necessary starting point (primer) for DNA polymerase. DNA polymerase I (or equivalent) later replaces these primers with DNA. DNA ligase seals the nicks between fragments. To prevent the loss of genetic material at the ends of linear chromosomes, telomerase adds repetitive sequences (telomeres). Proofreading mechanisms ensure a low error rate, and defects in these processes are linked to cancer and aging.

The replication fork involves several key proteins. Helicase breaks hydrogen bonds between bases. Single-Stranded Binding Proteins (SSB) prevent the strands from re-annealing. As helicase unwinds the DNA, supercoiling occurs ahead of the fork; Topoisomerases (like DNA gyrase in bacteria) cut and reseal the DNA to relieve this pressure. DNA polymerase III requires a free 3'-OH group to add the next deoxyribonucleotide, which is why Primase (an RNA polymerase) must first lay down an RNA primer. On the lagging strand, multiple primers are used. DNA polymerase I removes the RNA primers and fills the gaps. Finally, DNA Ligase catalyzes the formation of the phosphodiester bond to join the fragments. Eukaryotic replication is more complex, involving multiple origins of replication to handle larger genomes. Accuracy is maintained by the 3' to 5' exonuclease activity of DNA polymerase, which allows it to 'backspace' and correct mismatched bases.

Quinolone antibiotics (e.g., Ciprofloxacin) work by inhibiting bacterial DNA Gyrase (Topoisomerase), while some chemotherapy agents (e.g., Etoposide, Irinotecan) target eukaryotic topoisomerases. Telomerase activity is high in cancer cells, contributing to their 'immortality'. Understanding replication is essential for PCR (Polymerase Chain Reaction) technology used in diagnostics (e.g., COVID-19 testing). Genetic conditions like Lynch Syndrome involve defects in DNA mismatch repair, leading to early-onset colorectal cancer. Xeroderma Pigmentosum is caused by a defect in nucleotide excision repair of UV-damaged DNA.

Investigations involving DNA replication principles include: Genetic testing (Sanger sequencing or NGS), PCR for viral/bacterial detection, and Cytogenetics (Karyotyping). In oncology, microsatellite instability (MSI) testing is performed to check for DNA mismatch repair defects.

Pharmacological management includes the use of Antimetabolites (e.g., Methotrexate, 5-Fluorouracil) which interfere with nucleotide synthesis and DNA replication in rapidly dividing cancer cells. Antiviral drugs like Aciclovir act as chain terminators that inhibit viral DNA polymerase during replication of the Herpes virus. Management of DNA repair disorders focuses on prevention (e.g., strict UV protection in Xeroderma Pigmentosum).